N, N-dimethyltryptamine forms oxygenated metabolites via CYP2D6 - an in vitro investigation

References

• Buckholtz NS, Boggan WO. 1977. Monoamine oxidase inhibition in brain and liver produced by beta-carbolines: structure-activity relationships and substrate specificity. Biochem Pharmacol. 26(21):1991–1996. doi:10.1016/0006-2952(77)90007-7.
   PubMed Web of Science ®Google Scholar
• Caspar AT, Gaab JB, Michely JA, Brandt SD, Meyer MR, Maurer HH. 2018. Metabolism of the tryptamine-derived new psychoactive substances 5-MeO-2-Me-DALT, 5-MeO-2-Me-ALCHT, and 5-MeO-2-Me-DIPT and their detectability in urine studied by GC-MS, LC-MS(n), and LC-HR-MS/MS. Drug Test Anal. 10(1):184–195. doi:10.1002/dta.2197.
   PubMed Web of Science ®Google Scholar
• Crewe HK, Lennard MS, Tucker GT, Woods FR, Haddock RE. 1992. The effect of selective serotonin re-uptake inhibitors on cytochrome P4502D6 (CYP2D6) activity in human liver microsomes. Br J Clin Pharmacol. 34(3):262–265. doi:10.1111/j.1365-2125.1992.tb04134.x.
   PubMed Web of Science ®Google Scholar
• D'Souza DC, Syed SA, Flynn LT, Safi-Aghdam H, Cozzi NV, Ranganathan M. 2022. Exploratory study of the dose-related safety, tolerability, and efficacy of dimethyltryptamine (DMT) in healthy volunteers and major depressive disorder. Neuropsychopharmacology. 47(10):1854–1862. doi:10.1038/s41386-022-01344-y.
   PubMed Web of Science ®Google Scholar
• Dobkin de Rios M. 1971. Ayahuasca–the healing vine. Int J Soc Psychiatry. 17(4):256–269. doi:10.1177/002076407101700402.
   PubMed Web of Science ®Google Scholar
• Eckernäs E, Bendrioua A, Cancellerini C, Timmermann C, Carhart-Harris R, Hoffmann KJ, Ashton M. 2022. Development and application of a highly sensitive LC-MS/MS method for simultaneous quantification of N, N-dimethyltryptamine and two of its metabolites in human plasma. J Pharm Biomed Anal. 212:114642. doi:10.1016/j.jpba.2022.114642.
   PubMed Web of Science ®Google Scholar
• Food and Drug Administration 2020. In Vitro Drug Interaction Studies—Cytochrome P450 Enzyme- and Transporter-Mediated Drug Interactions Guidance for Industry. WA: US department of Health and Human Services FDA.
   Google Scholar
• Gomes MM, Coimbra JB, Clara RO, Dörr FA, Moreno AC, Chagas JR, Tufik S, Pinto E, Jr., Catalani LH, Campa A. 2014. Biosynthesis of N, N-dimethyltryptamine (DMT) in a melanoma cell line and its metabolization by peroxidases. Biochem Pharmacol. 88(3):393–401. doi:10.1016/j.bcp.2014.01.035.
   PubMed Web of Science ®Google Scholar
• Good M, Joel Z, Benway T, Routledge C, Timmermann C, Erritzoe D, Weaver R, Allen G, Hughes C, Topping H, et al. 2023. Pharmacokinetics of N, N-dimethyltryptamine in Humans. Eur J Drug Metab Pharmacokinet. 48(3):311–327. doi:10.1007/s13318-023-00822-y.
   PubMedGoogle Scholar
• Kamata T, Katagi M, Kamata HT, Miki A, Shima N, Zaitsu K, Nishikawa M, Tanaka E, Honda K, Tsuchihashi H. 2006. Metabolism of the psychotomimetic tryptamine derivative 5-methoxy-N, N-diisopropyltryptamine in humans: identification and quantification of its urinary metabolites. Drug Metab Dispos. 34(2):281–287. doi:10.1124/dmd.105.005835.
   PubMed Web of Science ®Google Scholar
• Luethi D, Kolaczynska KE, Vogt SB, Ley L, Erne L, Liechti ME, Duthaler U. 2022. Liquid chromatography-tandem mass spectrometry method for the bioanalysis of N, N-dimethyltryptamine (DMT) and its metabolites DMT-N-oxide and indole-3-acetic acid in human plasma. J Chromatogr B Analyt Technol Biomed Life Sci. 1213:123534. doi:10.1016/j.jchromb.2022.123534.
   PubMed Web of Science ®Google Scholar
• Malaca S, Bottinelli C, Fanton L, Cartiser N, Carlier J, Busardò FP. 2023. α-Methyltryptamine (α-MT) Metabolite Profiling in Human Hepatocyte Incubations and Postmortem Urine and Blood. Metabolites. 13(1):92. doi:10.3390/metabo13010092.
   PubMed Web of Science ®Google Scholar
• Manier SK, Felske C, Zapp J, Eckstein N, Meyer MR. 2021. Studies on the In Vitro and In Vivo Metabolic Fate of the New Psychoactive Substance N-Ethyl-N-Propyltryptamine for Analytical Purposes. J Anal Toxicol. 45(2):195–202. doi:10.1093/jat/bkaa060.
   PubMed Web of Science ®Google Scholar
• McIlhenny EH, Riba J, Barbanoj MJ, Strassman R, Barker SA. 2012. Methodology for determining major constituents of ayahuasca and their metabolites in blood. Biomed Chromatogr. 26(3):301–313. doi:10.1002/bmc.1657.
   PubMed Web of Science ®Google Scholar
• Michely JA, Brandt SD, Meyer MR, Maurer HH. 2017. Biotransformation and detectability of the new psychoactive substances N, N-diallyltryptamine (DALT) derivatives 5-fluoro-DALT, 7-methyl-DALT, and 5,6-methylenedioxy-DALT in urine using GC-MS, LC-MS(n), and LC-HR-MS/MS. Anal Bioanal Chem. 409(6):1681–1695. doi:10.1007/s00216-016-0117-5.
   PubMed Web of Science ®Google Scholar
• Michely JA, Helfer AG, Brandt SD, Meyer MR, Maurer HH. 2015. Metabolism of the new psychoactive substances N, N-diallyltryptamine (DALT) and 5-methoxy-DALT and their detectability in urine by GC-MS, LC-MSn, and LC-HR-MS-MS. Anal Bioanal Chem. 407(25):7831–7842. doi:10.1007/s00216-015-8955-0.
   PubMed Web of Science ®Google Scholar
• Palhano-Fontes F, Barreto D, Onias H, Andrade KC, Novaes MM, Pessoa JA, Mota-Rolim SA, Osório FL, Sanches R, Dos Santos RG, et al. 2019. Rapid antidepressant effects of the psychedelic ayahuasca in treatment-resistant depression: a randomized placebo-controlled trial. Psychol Med. 49(4):655–663. doi:10.1017/S0033291718001356.
   PubMed Web of Science ®Google Scholar
• Riba J, McIlhenny EH, Bouso JC, Barker SA. 2015. Metabolism and urinary disposition of N, N-dimethyltryptamine after oral and smoked administration: a comparative study. Drug Test Anal. 7(5):401–406. doi:10.1002/dta.1685.
   PubMed Web of Science ®Google Scholar
• Riba J, McIlhenny EH, Valle M, Bouso JC, Barker SA. 2012. Metabolism and disposition of N, N-dimethyltryptamine and harmala alkaloids after oral administration of ayahuasca. Drug Test Anal. 4(7-8):610–616. doi:10.1002/dta.1344.
   PubMed Web of Science ®Google Scholar
• Sanches RF, de Lima Osório F, Dos Santos RG, Macedo LR, Maia-de-Oliveira JP, Wichert-Ana L, de Araujo DB, Riba J, Crippa JA, Hallak JE. 2016. Antidepressant Effects of a Single Dose of Ayahuasca in Patients With Recurrent Depression: A SPECT Study. J Clin Psychopharmacol. 36(1):77–81. doi:10.1097/JCP.0000000000000436.
   PubMed Web of Science ®Google Scholar
• Szara S, Axelrod J. 1959. Hydroxylation and N-demethylation of N, N-dimethyltryptamine. Experientia. 15(6):216–217. doi:10.1007/BF02158111.
   PubMedGoogle Scholar
• Taylor C, Crosby I, Yip V, Maguire P, Pirmohamed M, Turner RM. 2020. A Review of the Important Role of CYP2D6 in Pharmacogenomics. Genes (Basel). 11(11):1295. doi:10.3390/genes11111295.
   PubMed Web of Science ®Google Scholar
• Tipton KF. 1986. Enzymology of monoamine oxidase. Cell Biochem Funct. 4(2):79–87. doi:10.1002/cbf.290040202.
   PubMed Web of Science ®Google Scholar
• Vogt SB, Ley L, Erne L, Straumann I, Becker AM, Klaiber A, Holze F, Vandersmissen A, Mueller L, Duthaler U, et al. 2023. Acute effects of intravenous DMT in a randomized placebo-controlled study in healthy participants. Transl Psychiatry. 13(1):172. doi:10.1038/s41398-023-02477-4.
   PubMed Web of Science ®Google Scholar
• Zhao T, He YQ, Wang J, Ding KM, Wang CH, Wang ZT. 2011. Inhibition of human cytochrome P450 enzymes 3A4 and 2D6 by β-carboline alkaloids, harmine derivatives. Phytother Res. 25(11):1671–1677. doi:10.1002/ptr.3458.
   PubMed Web of Science ®Google Scholar